News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
<Research>G Sachs Forecasts HK IPO Fundraising to Reach US$60B This Yr
Hong Kong regained the top spot in the global equity financing market in 2025, Goldman Sachs released a research report saying. Entering 2026, Hong Kong's IPO momentum has acce...
Reset
Send
The window will close in 5 seconds
<Research>G Sachs Forecasts HK IPO Fundraising to Reach US$60B This Yr
Close
Recommend
24
Positive
27
Negative
11
 
 

Hong Kong regained the top spot in the global equity financing market in 2025, Goldman Sachs released a research report saying. Entering 2026, Hong Kong's IPO momentum has accelerated. 40 companies have been listed YTD, raising US$14 billion (+488% YoY).

There are currently about 400 active applications, highlighting strong issuer confidence. Goldman Sachs' analysis indicates that existing capital is sufficient to absorb new issuance. The broker projected total equity supply to reach US$110 billion for 2026, including US$60 billion in new IPOs and US$50 billion in post-IPO financing.

Related News G Sachs: CICC (03908.HK) 1Q26 Preliminary Results Far Exceed Expectations, Reiterates Buy, TP HKD28.15
Goldman Sachs believed that the recovery in Hong Kong's IPO activity could drive stronger growth for HKEX (00388.HK)  -3.600 (-0.864%)    Short selling $213.47M; Ratio 18.022%   and Chinese brokers with more overseas business exposure.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-22 16:25.)

Auto-translated by AI

AASTOCKS Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.